DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹2,248 Cr | ₹1,755 Cr | ₹1,539 Cr | ₹2,454 Cr | ₹1,728 Cr |
What is the latest Total Current Liabilities ratio of DIVIS LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹2,248 Cr |
| Mar2024 | ₹1,755 Cr |
| Mar2023 | ₹1,539 Cr |
| Mar2022 | ₹2,454 Cr |
| Mar2021 | ₹1,728 Cr |
How is Total Current Liabilities of DIVIS LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,248 Cr | 28.09 | |
| Mar2024 | ₹1,755 Cr | 14.04 | |
| Mar2023 | ₹1,539 Cr | -37.30 | |
| Mar2022 | ₹2,454 Cr | 42.01 | |
| Mar2021 | ₹1,728 Cr | - | |
Compare Total Current Liabilities of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹172,308.2 Cr | 1.8% | 0.9% | 6.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,160.0 Cr | 1.7% | 7.3% | 0% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹126,440.0 Cr | 1.3% | 4.4% | 14.9% | Stock Analytics | |
| CIPLA | ₹123,149.0 Cr | 0.9% | -2.9% | 1.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,369.0 Cr | 0.5% | -3.1% | 3.3% | Stock Analytics | |
| MANKIND PHARMA | ₹92,837.8 Cr | 0.3% | -6.5% | -13.5% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 1.8% |
0.9% |
6.1% |
| SENSEX | 0.1% |
1.1% |
8.4% |
You may also like the below Video Courses